Public Health Alerts — A New Section in <i>NEJM Evidence</i> , in Partnership with CIDRAP
Chana A. Sacks(Harvard University), M. T. Osterholm(University of Minnesota), Jim Wappes(University of Minnesota), Robert H. Goldstein(Harvard University), Rochelle P. Walensky(Harvard University), Sonja A. Rasmussen(Johns Hopkins University), Lindsey R. Baden(Brigham and Women's Hospital), Richard A. Goodman(Centers for Disease Control and Prevention), Corey Hardin(University of California, Riverside), Eric J. Rubin(Harvard University)
Cited by 0
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
H1N1 2009 influenza virus infection during pregnancy in the USA
|The Lancet|2009|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k